Technical Data

M4688-25C
Clone Type
Polyclonal
Host
Goat
Source
Human
Isotype
IgG
Grade
Affinity Purified
Applications
E WB
Crossreactivity
Hu Mk Rt
Accession #
NP_005836.2
Shipping Temp
Blue Ice
Storage Temp
-20°C
Goat Anti-MRP4 (Multidrug Resistance-associated Protein 4, ATP-binding Cassette Sub-family C (CFTR/MRP) Member 4, ATP Binding Cassette Sub-family C Member 4, ABCC4, bA464I2.1, Canalicular Multispecific Organic Anion Transporter ABC Superfamily, Canalicular Multispecific Organic Anion Transporter, EST170205, MRP/cMOAT Related ABC Transporter, Multispecific Organic Anion Transporter B, MOATB, RP11-74A12.1)

Proteins involved in MDR mechanisms are P-glycoprotein (Pgp), Multidrug Resistance-associated Protein (MRP) and Lung Resistance-related Protein (LRP). Pgp and MRP belong to the ATP binding cassette (ABC) superfamily of membrane transporter proteins. This superfamily comprises a broad range of proteins found in organisms from bacteria to humans, which transport a wide variety of substances such as ions, amino acids, sugars, peptide and proteins. Although increased levels of Pgp are likely to contribute to MDR in at least some tumor types, it has become evident that alternative, non-Pgp-mediated mechanisms of MDR exist. The multidrug resistance-associated protein (MRP1) has been identified by Cole and Deeley. The amino acid identity between MRP1 and Pgp is only 15%, and the homology to chloride channel CFTR only 19%. Paulusma, et al., cloned the cDNA for rat canalicular multispecific organic anion transporter (cMOAT or MRP2) which turned out to be a novel liver specific homolog of human MRP1. Recently, by screening database of human expressed sequences tags, Kool identified three new homologs of MRP1, called MRP3, MRP4 and MRP5. Several excellent reviews appeared recently dealing with mechanisms of cellular drug resistance. In addition to MDR-related proteins many other mechanisms of drug resistance have been documented in vitro. They are based on alterations in drug target enzymes and proteins, increased detoxification, alterations in cellular metabolism, enhanced ability to repair DNA damage, and failure to undergo apoptosis.

Applications
Suitable for use in ELISA, Western Blot, Immunohistochemistry. Other applications not tested.
Recommended Dilution
ELISA: 1:64000 Western Blot:1-3ug/ml Optimal dilutions to be determined by the researcher.
Storage and Stability
May be stored at 4°C for short-term only. For long-term storage and to avoid repeated freezing and thawing, aliquot and store at -20°C. Aliquots are stable for at least 12 months at -20°C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer.
Immunogen
Synthetic peptide of ABCC4.
Form
Supplied as a liquid in Tris saline 0.5mg/ml, 0.02% sodium azide, pH 7.3, 0.5% BSA.
Purity
Purified by immunoaffinity chromatography.
Specificity
Recognizes human ABCC4 at ~170kD in rat renal cortex membranes (calculated MW of 149kDa according to Rat NP_596902.1 and 150kD according to Human NP_005836.2). This antibody is expected to recognize isoform 1 (NP_005836.2) only. Species Crossreactivity: Mouse and rat.

Intended for research use only. Not for use in human, therapeutic, or diagnostic applications.

References
1. Schuetz JD, Connelly MC, Sun D, Paibir SG, Flynn PM, Srinivas RV, Kumar A, Fridland A. MRP4: A previously unidentified factor in resistance to nucleoside-based antiviral drugs. Nat Med. 1999 Sep;5(9):1048-51.
USBio References
No references available
United States Biological | 4 Technology Way | Salem, MA 01970
Phone 800-520-3011 | Fax 978-594-8052 | Website www.usbio.net